Work

Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primary Breast Cancer

Year: 2003

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2003.02.063

Authors: I. Craig Henderson, Donald A. Berry, George D. Demetri, Constance T. Cirrincione, Lori J. Goldstein, Silvana Martino, James N. Ingle, M. Robert Cooper, Daniel F. Hayes, Katherine H. Tkaczuk, Gini Fleming, James F. Holland, David B. Duggan, John T. Carpenter, Emil Frei, Richard L. Schilsky, William C. Wood, Hyman B. Muss, Larry Norton

Institutions: The University of Texas MD Anderson Cancer Center, University of California, San Francisco, Georgetown University, North Central Cancer Treatment Group, Eastern Cooperative Oncology Group, Dana-Farber Cancer Institute, Wake Forest University Health Sciences, Wake Forest University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

Awards: Cancer and Leukemia Group B, G973482110

OpenAlex ID: W2135800076

FWCI: 43.77

Cites: 22

Cited by: 1,291

Related to: 10